
Kura spins out Caspian to test menin inhibitors for diabetes
Kura Oncology has spun out a new biotech startup, Caspian Therapeutics, to develop menin inhibitor drugs for diabetes and cardiometabolic diseases.
Every Medical Research story tagged diabetes.

Kura Oncology has spun out a new biotech startup, Caspian Therapeutics, to develop menin inhibitor drugs for diabetes and cardiometabolic diseases.

The American Diabetes Association concluded an internal review, stating five members were removed from its June annual meeting for disruptive conduct.

The American Diabetes Association denies censoring protest or involving police when expelling five members from its June scientific sessions.

An independent review commissioned by the American Diabetes Association found that attendees were removed from the June Scientific Sessions for disruptive conduct.

Verily Health, with NVIDIA and the NIH All of Us program, developed a foundation model combining EHR and genomic data. The model's performance for identifying high-risk Type 2 diabetes cases improved significantly, achieving a threefold pre-training efficiency gain.